Skip to main content
. 2018 Sep 14;4(1):127–133. doi: 10.1016/j.adro.2018.09.002

Table 1.

Patient demographics and clinical treatment characteristics

Category All (n = 145) Brain (n = 50) Bone (n = 95) P-value
Treating hospital, no. (%) .662
 Safety-net hospital 29 (20.0) 11 (22.0) 18 (18.9)
 Private hospital 116 (80.0) 39 (78.0) 77 (81.1)
Sex, no. (%) .015
 Male 81 (55.9) 21 (42.0) 60 (63.2)
 Female 64 (44.1) 29 (58.0) 35 (36.8)
Age, no. (%) .180
 <65 years 103 (71.0) 39 (78.0) 64 (67.4)
 65+ years 42 (29.0) 11 (22.0) 31 (32.6)
Race, no. (%) .264
 Non-Hispanic white 47 (32.4) 11 (22.0) 36 (37.9)
 Non-Hispanic black 27 (18.6) 10 (20.0) 17 (17.9)
 Hispanic 68 (46.9) 28 (56.0) 40 (42.1)
 Other 3 (2.1) 1 (2.0) 2 (2.1)
Preferred language, no. (%) .460
 English 87 (60.0) 27 (54.0) 60 (63.2)
 Spanish 54 (37.2) 22 (44.0) 32 (33.7)
 Creole 4 (2.8) 1 (2.0) 3 (3.2)
Comorbidity, no. (%) .757
 Low 105 (72.4) 37 (74.0) 68 (71.6)
 High 40 (27.6) 13 (26.0) 27 (28.4)
SES, no. (%) .671
 Low 71 (49.0) 27 (54.0) 44 (46.3)
 High 65 (44.8) 20 (40.0) 45 (47.4)
 Unknown 9 (6.2) 3 (6.0) 6 (6.3)
KPS, no. (%) .246
 Good 39 (31.5) 17 (39.5) 22 (27.2)
 Fair 63 (50.8) 21 (48.8) 42 (51.9)
 Poor 22 (17.7) 5 (11.6) 17 (21.0)
 Unknown 21 (14.5) 7 (14.0) 14 (14.7)
Projected fractions, no. (%) .006
 <10 18 (12.4) 1 (2.0) 17 (17.9)
 ≥10 127 (87.6) 49 (98.0) 78 (82.1)
Treatment interruption, no. (%) .499
 No 112 (77.2) 37 (74.0) 75 (78.9)
 Yes 33 (22.8) 13 (26.0) 20 (21.1)

Abbreviations: KPS = Karnofsky performance status; no. = number; SES = socioeconomic status.